| A systematic review of computational drug discovery, development, and repurposing for Ebola virus disease treatment J Schuler, ML Hudson, D Schwartz, R Samudrala Molecules 22 (10), 1777, 2017 | 28 | 2017 |
| Evaluating the performance of drug-repurposing technologies J Schuler, Z Falls, W Mangione, ML Hudson, L Bruggemann, ... Drug discovery today 27 (1), 49-64, 2022 | 23 | 2022 |
| Multiscale virtual screening optimization for shotgun drug repurposing using the CANDO platform ML Hudson, R Samudrala Molecules 26 (9), 2581, 2021 | 10 | 2021 |
| Multiscale virtual screening optimization for shotgun drug repurposing using the CANDO platform ML Hudson, R Samudrala bioRxiv, 2020.08. 24.265488, 2020 | 1 | 2020 |
| Supplementary Material: Evaluating Performance of Drug J Schuler, Z Falls, W Mangione, ML Hudson, L Bruggemann, ... | | 2020 |
| Discovery at the interface: novel anticancer agents targeting human estrogen receptor/S100 interactions DH Lee, BK Asare, ML Hudson, RV Rajnarayanan Cancer Research 74 (19_Supplement), 4173-4173, 2014 | | 2014 |
| Comparative analyses of human estrogen receptor-EF-hand protein complexes: molecular basis for hormone independent activation. DH Lee, BK Asare, S Singh, RV Rajnarayanan Cancer Research 73 (8 Supplement), 2891-2891, 2013 | | 2013 |
Ram SamudralaProfessor and Chief, Division of Bioinformatics, University at BuffaloVerified email at compbio.org
